Table 3.
Gene | SNP | Factor | Method | Sample | Case (%) | Control (%) | OR (95% CI) | p Value | Susceptibility | Reference |
---|---|---|---|---|---|---|---|---|---|---|
ERCC1 | rs3212986(ECCA) | AC + AA | PCR-RFLP | Blood | 68 (53.5) | 59 (40.7) | 1.68 (1.04–2.72) | 0.03 | Increase | Sun et al., 2018 [40] |
MTHFR | rs1801131 | CC | PCR-HRM | Tissues | 62 (35.4) | 72 (20.6) | 2.00 (1.14–3.48) | Increase | Songserm et al., 2011 [39] | |
NAT1 | * 11 | PCR-RFLP | Blood | 1 (0.2) | 11 (2.4) | 0.10 (0.00–0.58) | 0.005 | Decrease | Prawan et al., 2005 [38] | |
NAT2 | * 13 | PCR-RFLP | Blood | 8 (1.9) | 24 (5.2) | 0.35 (0.16–0.77) | 0.008 | Decrease | ||
rs1799930 | * 6B | PCR-RFLP | Blood | 6 (1.4) | 22 (4.7) | 0.28 (0.12–0.69) | 0.004 | Decrease | ||
rs1799931 | * 7A | PCR-RFLP | Blood | 9 (2.1) | 28 (6.0) | 0.33 (0.16–0.70) | 0.003 | Decrease | ||
MUTYH | rs3219476 | TG | PCR-RFLP | Blood | 20 (30.9) | 58 (58.0) | 0.36 (0.17–0.76) | 0.006 | Decrease | You et al., 2013 [42] |
rs3219472 | AA | PCR-RFLP | Blood | 12 (20.3) | 7 (7.0) | 2.82 (0.99–8.00) | 0.047 | Increase | ||
ABCC2 | rs3740066 | T | TaqMan | Blood | 47 (39.2) | 38 (26.0) | 1.83 (1.09–3.08) | 0.022 | Increase | Höblinger et al., 2009 [28] |